Here are relevant reports on : pediatric-oncology-market
-
Continuous Renal Replacement Therapy Market by Product (Hemofilter, Bloodline, Machines, Dialysates), Modality (SCUF, CVVH, CVVHD, CVVHDF), Age (Adult, Pediatric), Enduser (Hospitals, Ambulatory), and Region - Global Forecast to 2028
The global continuous renal replacement therapy market, valued at US$1.3 billion in 2022, stood at US$1.4 billion in 2023 and is projected to advance at a resilient CAGR of 8.1% from 2023 to 2028, culminating in a forecasted valuation of US$2.1 billion by the end of the period. Various factors such as rise in worldwide prevalence of AKI, Growing number of ICU patients with AKI and rising incidences of sepsis, and growing clinical advantage of CRRT over intermittent blood purification are factors likely to accelerate the growth of the market.
- Published: October 2023
- Price: $ 4950
- TOC Available:
-
Patient Simulation Market by Offering (High-fidelity Simulator, Software, Web-based), Technology (AI-integrated), Age (Pediatric, Adults), Indication (Respiratory, Emergency, Cardio), End User (Academic Institutes, Hospital) - Global Forecast to 2030
The Patient Simulation market, valued at USD 1.32 billion in 2024, stood at USD 1.54 billion in 2025 and is projected to advance at a resilient CAGR of 16.0% from 2025 to 2030, culminating in a forecasted valuation of USD 3.23 billion by the end of the period. The patient simulation market is experiencing steady growth as healthcare systems increasingly focus on structured clinical training and reducing errors.
- Published: May 2026
- Price: $ 4950
- TOC Available:
-
US Telehealth & Telemedicine Market by Function (Clinical Care, Teleconsult, RPM, Patient Engagement, Analytics), Application (TeleICU, Teleradiology, Telecardiology, Diabetes), Age (Adult, Pediatric), End User (Hospital, Payer, ASC) - Forecast to 2030
The US Telehealth & Telemedicine Market, valued at US$46.10 billion in 2024, stood at US$51.40 billion in 2025 and is projected to advance at a resilient CAGR of 10.2% from 2025 to 2030, culminating in a forecasted valuation of US$83.63 billion by the end of the period. In the US, permanent CMS reimbursement expansions and state-level payment parity laws are driving telehealth growth by securing fair, ongoing reimbursement comparable to in-person care.
- Published: May 2026
- Price: $ 4950
- TOC Available:
-
Cerebrospinal Fluid Management Market by Product (Shunts (Ventriculoperitoneal, Ventriculoatrial, Adjustable Valve), External Drainage Systems (EVD, Lumbar Drainage)), End User (Pediatric, Adult, Geriatric) - Global Forecast to 2022
The global cerebrospinal fluid management market is projected to reach USD 1.56 Billion by 2022 from an estimated USD 1.26 Billion in 2017, at a CAGR of 4.4% during the forecast period. The growth of this market is majorly driven by factors such as the growing geriatric population and the high prevalence of hydrocephalus and the subsequent increase in the number of shunting procedures. The key players in the global cerebrospinal fluid (CSF) management market are Medtronic (Ireland), Integra (US), B. Braun (Germany), DePuy Synthes (US), Spiegelberg GmbH & Co. KG (Germany), SOPHYSA (France), Natus Medical Incorporated (US), Dispomedica GmbH (Germany), Delta Surgical Limited (UK), Argi Grup (Turkey), Moller Medical GmbH (Germany), G. SURGIWEAR LTD. (India), and Wellong Instruments Co., Ltd. (Taiwan).
- Published: May 2018
- Price: $ 4950
- TOC Available:
-
Cardiac Surgery Instruments Market by Product (Clamps, Forceps, Scalpel, Scissors, Needle Holder), Application (Coronary Artery Bypass Graft, Heart Valve Surgery, Pediatric Surgery, Heart Transplant), & End User (Hospital, ASC) - Global Forecast to 2022
The cardiac surgery instruments market is expected to reach USD 1.63 Billion by 2022 from USD 1.16 Billion in 2017, at a CAGR of 7.1%. The market is mainly driven by factors such as high incidence of cardiac diseases, growing prevalence of cardiac conditions and the subsequent increase in the number of surgical procedures, rising geriatric population, and growing investments, funds, and grants by government bodies worldwide.
- Published: May 2017
- Price: $ 4950
- TOC Available:
-
Ventilators Market by Mobility (Intensive Care Ventilators, Transportable Ventilators), Type (Adult & Pediatric Ventilators), Interface (Hybrid Ventilation), Mode (Combined Mode Ventilation), Care Setting (Hospitals & Clinics) - Global Forecast to 2029
The global ventilators market, valued at US$3.86B in 2023, is forecasted to grow at a 4.7% CAGR, reaching US$3.71B by 2024 and US$4.66B by 2029. The demand for invasive and non-invasive ventilator systems has increased due to the rapidly growing geriatric population and the increasing rates of respiratory diseases such as pneumonia, ARDS, and COPD.
- Published: February 2025
- Price: $ 4950
- TOC Available:
-
Particle Therapy Market by Type (Proton Therapy, Heavy Ion), Products (Cyclotron, Synchrotron, Synchrocyclotron), Services, System (Single-room, Multi-room), Cancer Type (Pediatric, Prostate), Application (Treatment, Research) - Global Forecast to 2028
The global particle therapy market, valued at US$0.6 billion in 2022, stood at US$0.7 billion in 2023 and is projected to advance at a resilient CAGR of 8.2% from 2023 to 2028, culminating in a forecasted valuation of US$1.1 billion by the end of the period. Many factors, such as technological advancements, funding and reimbursement, strong healthcare funding, active research funding, a clear regulatory framework, growing minimally invasive procedure adoption, and the presence of key market players in developing regions are driving the growth of the particle therapy market
- Published: November 2023
- Price: $ 4950
- TOC Available:
-
Bunion Surgery Market by Product (Correction Systems, Implants & Accessories), Patient Type (Adult, Pediatric), Type (Minimally Invasive Surgery, Traditional Surgery), End User (Hospitals, ASCs, Orthopedic Clinics), Region - Global Forecast to 2029
The global bunion surgery market, valued at US$437.8 million in 2023, stood at US$458.4 million in 2024 and is projected to advance at a resilient CAGR of 5.7% from 2024 to 2029, culminating in a forecasted valuation of US$606.1 million by the end of the period. The main factor driving this market is the rising prevalence of bunions, which has led to an increased demand for surgical treatments.
- Published: January 2025
- Price: $ 4950
- TOC Available:
-
Neonatal Care Equipment Market by Product (Neonatal Incubators, Convertible Warmers & Incubators, Respiratory Care Devices (Neonatal Ventilators), Monitoring Devices (Pulse Oximeters)), End User (General and Pediatric Hospitals) - Global Forecast to 2030
The global neonatal care equipment market, valued at US$2.0 billion in 2024, stood at US$2.2 billion in 2025 and is projected to advance at a resilient CAGR of 5.6% from 2025 to 2030, culminating in a forecasted valuation of US$2.8 billion by the end of the period. The neonatal care equipment market is driven by rising preterm birth rates, advancements in neonatal technology, and increasing government initiatives to reduce infant mortality.
- Published: July 2025
- Price: $ 4950
- TOC Available:
-
Trocars Market by Product (Disposable, Reusable, Reposable), Tip (Bladeless Trocars, Bladed Trocars, Blunt Trocars, Optical), Application (General Surgery, Urology, Pediatric, Gynecological Surgery), End User (Hospitals) - Global Forecast to 2023
The global trocars market is expected to reach USD 763.2 million by 2023, at a CAGR of 7.2%. The major factors driving the growth of this market are the increasing prevalence of cancer and hernia and growing preference for minimally invasive surgery. Key players in the trocars market include Medtronic (Ireland), Ethicon (US), B. Braun (Germany), Applied Medical (US), Cooper Companies (US), Teleflex (US), ConMed (US), LaproSurge (UK), Purple Surgical (UK), and GENICON (US).
- Published: August 2018
- Price: $ 4950
- TOC Available:
Records 11 to 20 of 50
